Tumor-suppressive effects of psoriasin (S100A7) are mediated through the β-catenin/T cell factor 4 protein pathway in estrogen receptor-positive breast cancer cells

scientific article published on 20 October 2011

Tumor-suppressive effects of psoriasin (S100A7) are mediated through the β-catenin/T cell factor 4 protein pathway in estrogen receptor-positive breast cancer cells is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1074/JBC.M111.225466
P932PMC publication ID3248020
P698PubMed publication ID22016394
P5875ResearchGate publication ID51733098

P2093author name stringRamesh K Ganju
Lianbo Yu
Mohd W Nasser
Yadwinder S Deol
Xianghong Zou
P2860cites workPsoriasin (S100A7) expression and invasive breast cancerQ22010926
Psoriasin expression in mammary epithelial cells in vitro and in vivoQ24292122
A putative role for psoriasin in breast tumor progressionQ24298889
Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assemblyQ24312910
Gene from a psoriasis susceptibility locus primes the skin for inflammationQ24314913
S100A7 (psoriasin) expression is associated with aggressive features and alteration of Jab1 in ductal carcinoma in situ of the breastQ24805971
Beta-catenin regulates expression of cyclin D1 in colon carcinoma cellsQ27860717
Psoriasin interacts with Jab1 and influences breast cancer progressionQ28191754
Axin-mediated CKI phosphorylation of beta-catenin at Ser 45: a molecular switch for the Wnt pathwayQ28217024
Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathwayQ28505373
WNT and beta-catenin signalling: diseases and therapiesQ29616159
S100A7 (Psoriasin), highly expressed in ductal carcinoma in situ (DCIS), is regulated by IFN-gamma in mammary epithelial cellsQ33305131
S100A7-downregulation inhibits epidermal growth factor-induced signaling in breast cancer cells and blocks osteoclast formationQ33322536
Control of beta-catenin signaling in tumor development.Q33981342
Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancerQ34026054
Actin dynamics and cell-cell adhesion in epitheliaQ34132779
Molecular architecture of adherens junctionsQ34360617
Cannabinoid receptors, CB1 and CB2, as novel targets for inhibition of non-small cell lung cancer growth and metastasisQ34513406
Beta-catenin and Tcfs in mammary development and cancerQ34543461
Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasisQ34603580
The Wnt signal transduction pathway in stem cells and cancer cells: influence on cellular invasion.Q34688333
Wnt signaling in human cancerQ35076037
Comparative expression of the psoriasin (S100A7) and S100C genes in breast carcinoma and co-localization to human chromosome 1q21-q22.Q36685203
Slit-2 induces a tumor-suppressive effect by regulating beta-catenin in breast cancer cellsQ36897655
The role of LEF/TCF factors in neoplastic transformationQ37090101
E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancerQ37372547
The links between transcription, beta-catenin/JNK signaling, and carcinogenesisQ37578108
Involvement of the Wnt-β-catenin pathway in invasion and migration of oral squamous carcinoma cellsQ39650570
A simplified method for quantifying cell migration/wound healing in 96-well platesQ39731401
S100A7 (psoriasin) is induced by the proinflammatory cytokines oncostatin-M and interleukin-6 in human breast cancer.Q39747948
Wnt-1 regulates free pools of catenins and stabilizes APC-catenin complexesQ40018737
Reciprocal negative regulation between S100A7/psoriasin and beta-catenin signaling plays an important role in tumor progression of squamous cell carcinoma of oral cavity.Q40020050
The S100A7-c-Jun activation domain binding protein 1 pathway enhances prosurvival pathways in breast cancerQ40402282
The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumorsQ40949632
Human epidermal differentiation complex in a single 2.5 Mbp long continuum of overlapping DNA cloned in bacteria integrating physical and transcript mapsQ42604357
Cytoplasmic localization of beta-catenin is a marker of poor outcome in breast cancer patients.Q43199946
Psoriasin (S100A7) expression is associated with poor outcome in estrogen receptor-negative invasive breast cancerQ44509716
Stimulation of MCF-7 tumor progression in athymic nude mice by 17beta-estradiol induces WISP-2/CCN5 expression in xenografts: a novel signaling molecule in hormonal carcinogenesis.Q45261595
Oncostatin M secreted by skin infiltrating T lymphocytes is a potent keratinocyte activator involved in skin inflammationQ60240274
Genes encoding structural proteins of epidermal cornification and S100 calcium-binding proteins form a gene complex ("epidermal differentiation complex") on human chromosome 1q21Q71049670
Psoriasin: a novel chemotactic proteinQ71384309
Differential expression of psoriasin messenger RNA between in situ and invasive human breast carcinomaQ71614084
Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical stainingQ72313935
Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21Q83237938
P433issue52
P407language of work or nameEnglishQ1860
P921main subjectestrogen-receptor positive breast cancerQ18553636
P1104number of pages10
P304page(s)44845-44854
P577publication date2011-10-20
P1433published inJournal of Biological ChemistryQ867727
P1476titleTumor-suppressive effects of psoriasin (S100A7) are mediated through the β-catenin/T cell factor 4 protein pathway in estrogen receptor-positive breast cancer cells
P478volume286

Reverse relations

cites work (P2860)
Q40133231Cannabinoid receptor-2 agonist inhibits macrophage induced EMT in non-small cell lung cancer by downregulation of EGFR pathway.
Q33804642Differential role of psoriasin (S100A7) in estrogen receptor α positive and negative breast cancer cells occur through actin remodeling
Q37554595Distinct prognostic values of S100 mRNA expression in breast cancer
Q34419405FAAH inhibition enhances anandamide mediated anti-tumorigenic effects in non-small cell lung cancer by downregulating the EGF/EGFR pathway
Q37001259Functions of S100 proteins.
Q38703693Increased S100A15 expression and decreased DNA methylation of its gene promoter are involved in high metastasis potential and poor outcome of lung adenocarcinoma.
Q38118075Joining S100 proteins and migration: for better or for worse, in sickness and in health.
Q38105784Opposing functions of psoriasin (S100A7) and koebnerisin (S100A15) in epithelial carcinogenesis.
Q64086561Roles of β-catenin, TCF-4, and survivin in nasopharyngeal carcinoma: correlation with clinicopathological features and prognostic significance
Q37650123S100 protein family in human cancer
Q35206368S100 proteins in cancer
Q92964700S100 proteins: An emerging cynosure in pregnancy & adverse reproductive outcome
Q38913035S100A7 acts as a dual regulator in promoting proliferation and suppressing squamous differentiation through GATA-3/caspase-14 pathway in A431 cells
Q51371324S100A7 has an oncogenic role in oral squamous cell carcinoma by activating p38/MAPK and RAB2A signaling pathway.
Q33648719S100A7 promotes the migration, invasion and metastasis of human cervical cancer cells through epithelial-mesenchymal transition
Q34700918S100A8 and S100A9 are associated with colorectal carcinoma progression and contribute to colorectal carcinoma cell survival and migration via Wnt/β-catenin pathway
Q21195847The secreted protein S100A7 (psoriasin) is induced by telomere dysfunction in human keratinocytes independently of a DNA damage response and cell cycle regulators
Q98164431Unveiling functional heterogeneity in breast cancer multicellular tumor spheroids through single-cell RNA-seq
Q35041332miR-29b defines the pro-/anti-proliferative effects of S100A7 in breast cancer